Eli Lilly (LLY) is to acquire Orna Therapeutics. Acquisition valued at USD 2.4bln.
Newsquawk Staff ·
Eli Lilly (LLY) is to acquire Orna Therapeutics. Acquisition valued at USD 2.4bln.
What it means
Eli Lilly's acquisition of Orna Therapeutics for USD 2.4 billion marks a significant move in the biotech sector, reflecting confidence in innovative therapies. This deal could enhance Eli Lilly's pipeline and competitive position, but investors will want to assess its strategic fit and any integration risks. Overall, this acquisition might lead to increased interest in Pharmaceutical equities, particularly those involved in similar biotech space.
Sources
- Dutch PM says no European ally is willing to buy Russian crude
- Senior US Treasury trade official Eric Ettorre will leave to join Netflix (NFLX), reports Axios
- Ukrainian President Zelensky says negotiations between Ukraine, Russia and the US could take place as early as November 10th
- US Midterms (6 days out): Florida flips to a Republican early-vote lead and Kansas narrows further; Crystal Ball shifts House and Senate races towards Democrats
- Israeli election results show Netanyahu's bloc with 53 seats, Eisenkot's bloc with 47 and Arab parties with 19, following the counting of all votes excluding double-envelope ballots, i24 reports
Related headlines
- Atomic Energy Organization of Iran Spokesman says protocol for building small reactors with Russia is being finalized3 hours ago
- Al-Mayadeen correspondent in Iran says Iranian officials believe that Trump wants to bring the nuclear issue into the negotiations, which Iran rejects1 hour ago
- US EQUITY OPEN: Indices rangebound ahead of FOMC and major earnings1 hour ago
- Amphenol (APH) Q3 2026 (USD): Adj. EPS 0.80 (exp. 0.73), Sales 10.2bln (exp. 9.49bln)3 hours ago
- GE Vernova (GEV) expects USD 50-100mln of annual cost synergies from Trench by 2030, according to the conference call3 hours ago
- Etsy Inc. (ETSY) Q3 2026 (USD): EPS 1.00 (exp. 0.77), Revenue 692mln (exp. 668mln)4 hours ago
- Garmin Ltd. (GRMN) Q3 2026 (USD): Adj. EPS 2.76 (exp. 2.41), Revenue 1.99bln (exp. 1.99bln)4 hours ago
- Phillips 66 (PSX) Q3 2026 (USD): Adj. EPS 14.08 (exp. 11.73)4 hours ago
- Atlanta Fed GDPNow (Q3) 3.3% (prev. 3.4%)31 min ago
- Eli Lilly’s (LLY) retatrutide delivered greater A1C reduction and more than double the weight loss of Novo Nordisk’s (NOVOB DC) Ozempic at its highest approved dose in head-to-head trial4 hours ago
- UK DMO says gross gilt issuance planned for 2026/27 is GBP 250.6bln (exp. 249.6bln, prev. 246.2bln in April remit)1 hour ago
- Daily US Conference Calendar - 28th October 2026: JNJ, BA, CAT4 hours ago
- Automatic Data Processing (ADP) Q3 2026 (USD): Adj. EPS 2.82 (exp. 2.77), Revenue 5.5bln (exp. 5.48bln). FY revenue growth view of 6%, adj. EPS growth view of 10-12% 4 hours ago
- JPMorgan Chase (JPM) reportedly faces an additional GBP 100-150mln tax bill following the UK government's decision to double the corporation tax surcharge on banks, potentially jeopardising plans for its new London headquarters, Sky News reports56 min ago
- T-Mobile (TMUS) CEO to step down from the board2 hours ago